Patent US3936470A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3936470A Expired / Lapsed US ⏱️ 0.0 years remaining

1,3-Dioxolan-2-ylmethylimidazoles

Assignee: Janssen Pharmaceutica NV
•
Filing: 1975-01-27
•
Granted: 1976-02-03
•
Expires: 1995-01-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel 1-(2-Ar 1 -4-Ar 2 -1,3-dioxolan-2-ylmethyl)imidazoles, 1-[2-Ar 1 -4-(Ar 2 -oxymethyl)-1,3-dioxolan-2-ylmethyl]imidazoles, 1-[2-Ar 1 -4-(Ar 2 -thiomethyl)-1,3-dioxolan-2-ylmethyl]imidazoles, and 1-[2-Ar 1 -4-(Ar 2 -ethyl)-1,3-dioxolan-2-ylmethyl]imidazoles, useful as antifungal and antibacterial agents.

Inventors

  • 👤 Jan Heeres

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 22:52
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/54; C07D233/56; A; A01; A01N; A01N43/00; A01N43/48; A01N43/50; C07C; C07C29/00; C07C29/09; C07C29/10; C07C29/103; C07C29/106; C07C29/36; C07D231/00; C07D231/02; C07D231/10; C07D231/12; C07D249/00; C07D249/02; C07D249/08; C07D303/00; C07D303/02; C07D303/04; C07D303/08; C07D303/12; C07D303/18; C07D303/20; C07D303/22; C07D317/00; C07D317/08; C07D317/10; C07D317/14; C07D317/16; C07D317/18; C07D317/22; C07D317/24; C07D317/30

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 122 words
A chemical compound selected from the group consisting of an imidazole derivative having the formula: ##EQU6## and the therapeutically active acid addition salts and stereochemical optical isomeric forms thereof, wherein: Ar 1 is a member selected from the group consisting of phenyl, mono-, di- and trihalophenyl, loweralkylphenyl and loweralkoxyphenyl; Ar 2 is a member selected from the group consisting of phenyl, substituted phenyl, naphthyl and halonaphthyl, and wherein substituted phenyl has the meaning of a phenyl group, having thereon from 1 to 3 substituents, independently selected from the group consisting of halo, loweralkyl, loweralkoxy, cyano, phenyl and benzyl; X is a member selected from the group consisting of O, S and CH 2 ; and n is the integer 0 or 1.
Claim 2
Dependent Claim 122 words
A chemical compound selected from the group consisting of an imidazole derivative having the formula: ##EQU6## and the therapeutically active acid addition salts and stereochemical optical isomeric forms thereof, wherein: Ar 1 is a member selected from the group consisting of phenyl, mono-, di- and trihalophenyl, loweralkylphenyl and loweralkoxyphenyl; Ar 2 is a member selected from the group consisting of phenyl, substituted phenyl, naphthyl and halonaphthyl, and wherein substituted phenyl has the meaning of a phenyl group, having thereon from 1 to 3 substituents, independently selected from the group consisting of halo, loweralkyl, loweralkoxy, cyano, phenyl and benzyl; X is a member selected from the group consisting of O, S and CH 2 ; and n is the integer 0 or 1.
Claim 3
Dependent Claim 18 words
A chemical compound selected from the group consisting of A-1-[2-(2,4-dichlorophenyl)-4-(p-fluorophenoxymethyl)-1,3-dioxolan-2-ylmethyl]imidazole and the therapeutically acceptable acid addition salts thereof.
Claim 4
Dependent Claim 18 words
A chemical compound selected from the group consisting of A-1-[2-(2,4-dichlorophenyl)-4-(p-fluorophenoxymethyl)-1,3-dioxolan-2-ylmethyl]imidazole and the therapeutically acceptable acid addition salts thereof.
Claim 5
Dependent Claim 18 words
A chemical compound selected from the group consisting of A-1-[4-(p-bromophenoxymethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-2-ylmethyl]imidazole and the therapeutically acceptable acid addition salts thereof.
Claim 6
Dependent Claim 18 words
A chemical compound selected from the group consisting of A-1-[4-(p-bromophenoxymethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-2-ylmethyl]imidazole and the therapeutically acceptable acid addition salts thereof.
Claim 7
Dependent Claim 18 words
A chemical compound selected from the group consisting of A-1-[2-(2,4-dichlorophenyl)-4-(p-methoxyphenoxymethyl)-1,3-dioxolan-2-ylmethyl]imidazole and the therapeutically acceptable acid addition salts thereof.
Claim 8
Dependent Claim 18 words
A chemical compound selected from the group consisting of A-1-[2-(2,4-dichlorophenyl)-4-(p-methoxyphenoxymethyl)-1,3-dioxolan-2-ylmethyl]imidazole and the therapeutically acceptable acid addition salts thereof.
Claim 9
Dependent Claim 18 words
A chemical compound selected from the group consisting of A-1-[2-(2,4-dichlorophenyl)-4-(2-fluorophenoxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazole and the therapeutically acceptable acid addition salts thereof.
Claim 10
Dependent Claim 18 words
A chemical compound selected from the group consisting of A-1-[2-(2,4-dichlorophenyl)-4-(2-fluorophenoxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazole and the therapeutically acceptable acid addition salts thereof.
Claim 11
Dependent Claim 18 words
A chemical compound selected from the group consisting of A-1-[4-(4-bromophenoxymethyl)-2-(4-chlorophenyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazole and the therapeutically acceptable acid addition salts thereof.
Claim 12
Dependent Claim 18 words
A chemical compound selected from the group consisting of A-1-[4-(4-bromophenoxymethyl)-2-(4-chlorophenyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazole and the therapeutically acceptable acid addition salts thereof.

References Cited (Backward Citations)

US3575999A Cited
US3717655A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-02-02 1979-08-04 1980-02-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-02-02 1983-08-04 1984-02-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-02-02 1987-08-04 1988-02-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag